SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 87 filers reported holding SUMMIT THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.92 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $63 | +200.0% | 25,114 | +101.9% | 0.00% | – |
Q1 2023 | $21 | -67.7% | 12,436 | -19.9% | 0.00% | – |
Q4 2022 | $65 | – | 15,529 | +24549.2% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 63 | -96.0% | 0.00% | – |
Q4 2021 | $4,000 | -76.5% | 1,578 | -27.8% | 0.00% | – |
Q3 2021 | $17,000 | -19.0% | 2,185 | -25.1% | 0.00% | – |
Q2 2021 | $21,000 | – | 2,916 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polar Capital Holdings Plc | 5,800,000 | $27,260,000 | 0.16% |
Inscription Capital, LLC | 17,000 | $80,000 | 0.03% |
ExodusPoint Capital Management, LP | 185,844 | $873,000 | 0.01% |
HoyleCohen, LLC | 10,359 | $49,000 | 0.01% |
Virtu Financial LLC | 10,835 | $51,000 | 0.01% |
Tower Research Capital LLC (TRC) | 3,783 | $18,000 | 0.00% |
Renaissance Technologies | 253,212 | $1,190,000 | 0.00% |
Baillie Gifford | 372,261 | $1,749,000 | 0.00% |
CAPSTONE INVESTMENT ADVISORS, LLC | 37,238 | $175,000 | 0.00% |
BREWIN DOLPHIN LTD | 1,970 | $9,259 | 0.00% |